Targeting phosphorylated p53 to elicit tumor-reactive T helper responses against head and neck squamous cell carcinoma-Reference-Cited by-同舟云学术

Targeting phosphorylated p53 to elicit tumor-reactive T helper responses against head and neck squamous cell carcinoma

Published:2018-08 Issue:9 Volume:7 Page:e1466771
ISSN:2162-402X
Container-title:OncoImmunology
language:en
Short-container-title:OncoImmunology

Author:

Ohara Kenzo¹²,Ohkuri Takayuki¹,Kumai Takumi¹²³,Nagato Toshihiro¹²,Nozaki Yui¹²,Ishibashi Kei¹⁴,Kosaka Akemi¹,Nagata Marino¹,Harabuchi Shohei¹²,Ohara Mizuho¹⁴,Oikawa Kensuke¹,Aoki Naoko¹,Harabuchi Yasuaki²,Celis Esteban⁵,Kobayashi Hiroya¹

Affiliation:

1. Department of Pathology, Asahikawa Medical University, Asahikawa, Japan

2. Department of Otolaryngology-Head and Neck surgery, Asahikawa Medical University, Asahikawa, Japan

3. Department of Innovative Head & Neck Cancer Research and Treatment (IHNCRT), Asahikawa Medical University, Asahikawa, Japan

4. Department of surgery, Asahikawa Medical University, Asahikawa, Japan

5. Cancer Immunology, Inflammation and Tolerance Program, Augusta University, Georgia Cancer Center, Augusta, GA

Funder

Japan Society for the Promotion of Science

Publisher

Informa UK Limited

Subject

Oncology,Immunology,Immunology and Allergy

Link

https://www.tandfonline.com/doi/pdf/10.1080/2162402X.2018.1466771

Reference43 articles.

1. Cisplatin, Fluorouracil, and Docetaxel in Unresectable Head and Neck Cancer

2. Nivolumab for Recurrent Squamous-Cell Carcinoma of the Head and Neck

3. Annual Report to the Nation on the Status of Cancer, 1975–2009, Featuring the Burden and Trends in Human Papillomavirus (HPV)–Associated Cancers and HPV Vaccination Coverage Levels

4. Peptide vaccines in cancer — old concept revisited

Cited by 15 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Analysis of Th1/Th2 cytokine profile and clinical characteristics of patients with head and neck squamous cell carcinoma;Biomolecules and Biomedicine;2024-06-24

2. 次世代リーダーの育成―頭頸部癌に対する免疫療法の最前線―;Nippon Jibiinkoka Tokeibugeka Gakkai Kaiho(Tokyo);2023-02-20

3. Post-Translational Modifications in Tumor-Associated Antigens as a Platform for Novel Immuno-Oncology Therapies;Cancers;2022-12-26

4. Mitogen‐activated protein kinase inhibition augments the T cell response against HOXB7 ‐expressing tumor through human leukocyte antigen upregulation;Cancer Science;2022-11-28

5. 功成り名遂げて身退くは, 天の道なり;Nippon Jibiinkoka Tokeibugeka Gakkai Kaiho(Tokyo);2022-10-20